KLOW BlendInterpret the evidence
Why Tendon Strength and Inflammation Are Separate Outcomes in KLOW Research
2 numbered sourcesSource years 2026
A peptide is a short chain of amino acids held together by peptide bonds. Different peptide materials can be investigated for different biological effects. KLOW is a blend label that refers here to BPC-157, TB-500, KPV and GHK-Cu. Research about its individual ingredients sometimes uses broad language about recovery. Looking at the actual outcomes is more informative, because a marker of inflammation and the strength of healing tissue answer different questions. [1, 2]
In a 2026 rat study, Biçer and colleagues assessed injured Achilles tendons after experimental repair. They compared separate groups for BPC-157, a reagent labeled TB-500, the pair and a control. The researchers measured how much force the tissue could withstand and examined tissue structure under a microscope. The TB-500-labeled group had a statistically significant difference from control in maximum load before failure. The combined group did not establish an added overall advantage. Neither KPV nor GHK-Cu was part of the study. [1]
The 2026 FDA briefing on KPV describes a different evidence base, including studies that asked about inflammatory pathways. A change in a marker related to inflammation may help explain a biological process, but it cannot stand in for a mechanical strength test. Conversely, a mechanically stronger specimen does not by itself establish that pain or movement improved. [1, 2]
For a mixture, it matters whether the same experiment actually measured both outcomes after studying the full material. The separate lines of evidence can help researchers choose which questions to examine. They do not show that the four ingredients together improve a person's recovery, pain or physical function.
Sources
Original works cited in this article. Links open the external record in a new tab.
